C.M. Bidwell & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

C.M. Bidwell & Associates’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.6K	Hold	75	–	–	0.01%	270
2026 Q1	$15.1K	Hold	75	–	–	0.01%	269
2025 Q4	$15.5K	Hold	75	–	–	0.01%	266
2025 Q3	$13.4K	Hold	75	–	–	0.01%	275
2025 Q2	$12.1K	Hold	75	–	–	0.01%	273
2025 Q1	$12.8K	Hold	75	–	–	0.01%	266
2024 Q4	$12.5K	Hold	75	–	–	0.01%	274
2024 Q3	$12.9K	Hold	75	–	–	0.01%	272
2024 Q2	$11.5K	Hold	75	–	–	0.01%	277
2024 Q1	$11.5K	Hold	75	–	–	0.01%	281
2023 Q4	$11.9K	Hold	75	–	–	0.01%	291
2023 Q3	$11K	Hold	75	–	–	0.01%	354
2023 Q2	$11.5K	Hold	75	–	–	0.01%	366
2023 Q1	$11.6K	Hold	75	–	–	0.01%	361
2022 Q4	$11.6K	Hold	75	–	–	0.01%	351
2022 Q3	$10K	Hold	75	–	–	0.01%	349
2022 Q2	$10K	Hold	75	–	–	0.01%	347
2022 Q1	$11K	Hold	75	–	–	0.01%	358
2021 Q4	$12K	Hold	75	–	–	0.01%	376
2021 Q3	$12K	Buy	+75	New	+$12.8K	0.01%	378

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

C.M. Bidwell & Associates's FBT Position: Q2 2026 in Review

C.M. Bidwell & Associates held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 75 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #270.

C.M. Bidwell & Associates first reported a position in FBT in Q3 2021 and has held it in 20 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

C.M. Bidwell & Associates held 75 shares of First Trust NYSE Arca Biotechnology Index Fund worth $18.6K as of Q2 2026.
C.M. Bidwell & Associates left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #270 holding.
C.M. Bidwell & Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2021 and has held it in 20 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.